Q4 2017 13F Holders as of 31 Dec 2017
-
Type / Class
-
Equity / Common Stock, par value $0.01 per share
-
Shares outstanding
-
183,255,226
-
Total 13F shares
-
60,500,377
-
Share change
-
+5,651,432
-
Total reported value
-
$1,095,067,241
-
Put/Call ratio
-
18%
-
Price per share
-
$18.10
-
Number of holders
-
120
-
Value change
-
+$103,341,807
-
Number of buys
-
71
-
Number of sells
-
35
Institutional Holders of HERON THERAPEUTICS, INC. /DE/ - Common Stock, par value $0.01 per share (HRTX) as of Q4 2017
As of 31 Dec 2017,
HERON THERAPEUTICS, INC. /DE/ - Common Stock, par value $0.01 per share (HRTX) was held by
120 institutional
shareholders
that filed Form 13F with the SEC.
Together, they reported ownership of
60,500,377 shares.
The largest 10 holders included
FMR LLC, FRANKLIN RESOURCES INC, JANUS HENDERSON GROUP PLC, BAKER BROS. ADVISORS LP, BlackRock Inc., Vanguard Group Inc, STATE STREET CORP, Rubric Capital Management LP, Broadfin Capital, LLC, and KINGDON CAPITAL MANAGEMENT, L.L.C..
This page lists
120
institutional shareholders reporting positions in this security
for the Q4 2017 filing period.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price
|
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.